But this study challenges that narrative, showing that a hormone we thought of only as a metabolic regulator may interfere with muscle repair and growth. The findings also raise new questions about the long-term use of GLP-1based drugs, such as those prescribed for type 2 diabetes and obesity
Pharmacological treatment of obesity is associated with post-cessation weight regain or weight cycling a further concern in the context of sarcopenia
Simple aftercare helps: keep the area clean, stay hydrated, avoid alcohol, heat and intense exercise for the first day or two
Treatment for hepatorenal syndrome, if this is present
Semaglutide Salts: These are modified chemical structures
A randomized, placebo-controlled trial published in Diabetes, Obesity and Metabolism found that semaglutide led to a 24% reduction in total daily energy intake compared to placebo, driven primarily by reduced appetite and fewer food cravings rather than nausea or food aversion